Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - Chronic Obstructive Pulmonary Disease
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

experspadmin

New Targets in Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy

New Targets in Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy

expert roundtables
By Carla M. Nester, MD, MSA, FASN; Jai Radhakrishnan, MD, MS; Richard Lafayette, MD, FACP

Prognostic Indicators in Early-Stage HER2+ Breast Cancer

Prognostic Indicators in Early-Stage HER2+ Breast Cancer

patient care perspectives
By Joseph A. Sparano, MD, FACP

Systemic Treatments for Advanced, Well-Differentiated, Small-Bowel Neuroendocrine Tumors That Progress on Somatostatin Analogues

Systemic Treatments for Advanced, Well-Differentiated, Small-Bowel Neuroendocrine Tumors That Progress on Somatostatin Analogues

clinical topic updates
By Jonathan R. Strosberg, MD

Waning Control of Diarrhea 3 to 4 Weeks After Long-Acting Somatostatin Analogue Injection

Waning Control of Diarrhea 3 to 4 Weeks After Long-Acting Somatostatin Analogue Injection

patient care perspectives
By Jonathan R. Strosberg, MD

Expert Perspectives in Adolescent Vaccinations to Cover Key Topics in Adolescent Vaccination

Infectious Diseases

Expert Perspectives in Adolescent Vaccinations to Cover Key Topics in Adolescent Vaccination

expert perspectives
By Tom Iarocci, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?